节点文献

提高对甲状腺素转运蛋白淀粉样变性心肌病诊治的认识

Recognition of Improving Diagnosis and Treatment of Transthyretin Amyloid Cardiomyopathy

  • 推荐 CAJ下载
  • PDF下载
  • 不支持迅雷等下载工具,请取消加速工具后下载。

【作者】 王前程; 刘伟涛; 周忠江;

【Author】 WANG Qiancheng;LIU Weitao;ZHOU Zhongjiang;Department of Cardiology,Nanfang Hospital,Southern Medical University;

【通讯作者】 周忠江;

【机构】 南方医科大学南方医院心血管内科;

【摘要】 甲状腺素转运蛋白淀粉样变性心肌病(ATTR-CM)是由于甲状腺素转运蛋白解离成单体后错误折叠为淀粉样物质,沉积于心肌间质而导致的一种心肌病。ATTR-CM主要分为突变型和野生型,临床表现无典型症状和体征。为提高国内在ATTR-CM的诊疗实践和临床研究,现简要介绍国内外关于ATTR-CM的最新诊断标准及治疗方法。

【Abstract】 Transthyretin amyloid cardiomyopathy is caused by the wrong folding of transthyretin into amyloid substance after dissociation into monomer and deposition in myocardial interstitium. Transthyretin amyloid cardiomyopathy,which is no typical clinical symptoms and signs,is mainly divided into mutant type and wild type. In order to improve the diagnosis and treatment practice and clinical research of transthyretin amyloid cardiomyopathy in China,this paper briefly introduces the latest diagnostic criteria and treatment methods of transthyretin amyloid cardiomyopathy around the world.

  • 【文献出处】 心血管病学进展 ,Advances in Cardiovascular Diseases , 编辑部邮箱 ,2021年03期
  • 【分类号】R542.2
  • 【下载频次】271
节点文献中: 

本文链接的文献网络图示:

本文的引文网络